Obesity: an indication rather than contraindication to laparoscopic cholecystectomy

Area of Science:

• Surgical Innovation
• Bariatric Surgery
• Gastrointestinal Surgery

Background:

• Obesity was initially a contraindication for laparoscopic cholecystectomy.
• Surgical experience has led to its consideration as an indication.
• Obese patients face higher risks with traditional open surgery.

Purpose of the Study:

• To evaluate the safety and efficacy of laparoscopic cholecystectomy in obese and morbidly obese patients.
• To compare outcomes between normal weight, obese, and morbidly obese patients undergoing the procedure.
• To determine if obesity impacts surgical outcomes.

Main Methods:

• Retrospective analysis of 325 consecutive laparoscopic cholecystectomy patients.
• Patients categorized into normal (Group I), obese (Group II), and morbidly obese (Group III) based on BMI.
• Outcomes analyzed included conversion rates, complications, mortality, hospital stay, and return to activity.

Main Results:

• Operative time was similar for normal and obese groups, but 23% longer for the morbidly obese.
• No statistically significant differences in conversion rates, complications, mortality, or return to activity were observed.
• Slightly longer operative time in the morbidly obese group was the only significant difference.

Conclusions:

• Laparoscopic cholecystectomy is a safe and effective treatment for obese and morbidly obese individuals.
• It should be the preferred procedure, avoiding complications associated with prolonged immobility and wound healing in these patients.
• The study supports the expansion of laparoscopic cholecystectomy indications to include obese patient populations.